Chrome Extension
WeChat Mini Program
Use on ChatGLM

Shared germline genomic variants in two patients with double primary gastrointestinal stromal tumours (GISTs).

David S Moura, Daniel López López,Davide di Lernia,Marta Martin-Ruiz,Maria Lopez-Alvarez,Rafael Ramos, Jose Merino, Joaquin Dopazo, Jose Lopez-Guerrero,Jose L Mondaza-Hernandez, Pablo Romero,Nadia Hindi, Jesus Garcia-Foncillas, Javier Martin-Broto

Journal of medical genetics(2024)

Cited 0|Views0
No score
Abstract
BACKGROUND:Gastrointestinal stromal tumours (GISTs) are prevalent mesenchymal tumours of the gastrointestinal tract, commonly exhibiting structural variations in KIT and PDGFRA genes. While the mutational profiling of somatic tumours is well described, the genes behind the susceptibility to develop GIST are not yet fully discovered. This study explores the genomic landscape of two primary GIST cases, aiming to identify shared germline pathogenic variants and shed light on potential key players in tumourigenesis. METHODS:Two patients with distinct genotypically and phenotypically GISTs underwent germline whole genome sequencing. CNV and single nucleotide variant (SNV) analyses were performed. RESULTS:Both patients harbouring low-risk GISTs with different mutations (PDGFRA and KIT) shared homozygous germline pathogenic deletions in both CFHR1 and CFHR3 genes. CNV analysis revealed additional shared pathogenic deletions in other genes such as SLC25A24. No particular pathogenic SNV shared by both patients was detected. CONCLUSION:Our study provides new insights into germline variants that can be associated with the development of GISTs, namely, CFHR1 and CFHR3 deep deletions. Further functional validation is warranted to elucidate the precise contributions of identified germline mutations in GIST development.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined